STRATA Skin Sciences (SSKN) Proxy Filing summary

Executive summary

• Annual meeting scheduled for December 10, 2025, to elect five directors, amend the 2016 Equity Incentive Plan, and ratify the external auditor appointment.

• Shareholders of record as of October 13, 2025, are eligible to vote in person, by proxy card, phone, or internet.

• Proxy materials distributed starting November 7, 2025, with voting results to be published in a Form 8-K.

Voting matters and shareholder proposals

• Proposals include electing five directors, amending the 2016 Equity Incentive Plan to add 520,000 shares, and ratifying CBIZ CPAs P.C. as auditor for 2025.

• Shareholder proposals for the 2026 meeting must be submitted by July 10, 2025, for proxy inclusion.

• Directors are elected by plurality; other proposals require a majority of shares present and entitled to vote.

Board of directors and corporate governance

• Board consists of a majority of independent directors per NASDAQ standards.

• Board committees: Audit and Compensation/Nominating & Governance, each with independent members.

• Board met 12 times in the last fiscal year; all directors attended at least 75% of meetings.

• Board diversity: 3 male, 2 female directors; broad mix of industry, financial, and governance experience.

• Code of Conduct and whistleblower policies in place; insider trading policy enforced.